P&T Community January 9, 2020
SANTA CLARA, Calif., — US healthcare venture fundraising reached $10.7B in 2019, setting a record for the third consecutive year, according to Silicon Valley Bank (SVB) (NASDAQ: SIVB), the bank of the world’s most innovative companies and their investors. Investment into venture-backed biopharma, medical device and diagnostics and tools (Dx/Tools) and healthtech reached $32B in 2019, only slightly down from 2018.
“In 2019, public markets created significant mark-ups with up-round IPOs and positive post-IPO performance for biopharma, dx/tools, device and healthtech companies,” said report author Jon Norris, Managing Director of SVB’s Life Science and Healthcare Practice. “Strong M&A and IPO performance also led to greater returns for limited partners, further driving fundraising and investment.”
SVB’s annual Healthcare Investments and Exits...
Today's Sponsors
Today's Sponsor